Ginsenoside Rb1 inhibits ferroptosis to ameliorate hypoxic-ischemic brain damage in neonatal rats
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110503 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Min Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, the Second School of Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,…. Hauptthemen laut MEDLINE: Ferroptosis, Hypoxia-Ischemia, Brain, Neuroprotective Agents. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Wenzhou Medical University, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Hypoxic ischemic encephalopathy (HIE) is among the leading causes of neonatal mortality, and currently there is no effective treatment. Ginsenoside Rb1 (GsRb1) is one of the principal active components of ginseng, and has protective benefits against oxidative stress, inflammation, hypoxic injury, and so on. However, the role and underlying mechanism of GsRb1 on HIE are unclear. Here, we established the neonatal rat hypoxic-ischemic brain damage (HIBD) model in vivo and the PC12 cell oxygen-glucose deprivation (OGD) model in vitro to investigate the neuroprotective effects of GsRb1 on HIE, and illuminate the potential mechanism. Our results showed that GsRb1 and the ferroptosis inhibitor liproxstatin-1 (Lip-1) could significantly restore System Xc activity and antioxidant levels as well as inhibit lipid oxidation levels and inflammatory index levels of HIBD and OGD models. Taken together, GsRb1 might inhibit ferroptosis to exert neuroprotective effects on HIE through alleviating oxidative stress and inflammation, which will set the foundation for future research on ferroptosis by reducing hypoxic-ischemic brain injury and suggest that GsRb1 might be a promising therapeutic agent for HIE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, the Second School of Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Basic Medical Research Center, the Second A…
- Department of Pediatrics, the Second School of Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Spinal Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Orthopaedics, the Second School of Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Clinical Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Pediatrics, the Second School of Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Key Laboratory of Perinatal Medicine of Wen…
Förderung
- Wenzhou Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Medical Science and Technology Project of Zhejiang Province
- Science and Technology Plan Project of Wenzhou Municipality
Zitieren
APA
Zhang, M., Lin, W., Tao, X., Zhou, W., Liu, Z., Zhang, Z., Jin, S., Zhang, H., Teng, C., Zhu, J., Guo, X., & Lin, Z. (2023). Ginsenoside Rb1 inhibits ferroptosis to ameliorate hypoxic-ischemic brain damage in neonatal rats. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110503
Vancouver
Zhang M, Lin W, Tao X, Zhou W, Liu Z, Zhang Z, et al. Ginsenoside Rb1 inhibits ferroptosis to ameliorate hypoxic-ischemic brain damage in neonatal rats. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110503
BibTeX
@article{Zhang2023,
author = {Zhang, Min and Lin, Wei and Tao, Xiaoyue and Zhou, Wei and Liu, Zhiming and Zhang, Zhe and Jin, Shuqing and Zhang, Haojie and Teng, Cheng and Zhu, Jianghu and Guo, Xiaoling and Lin, Zhenlang},
title = {Ginsenoside Rb1 inhibits ferroptosis to ameliorate hypoxic-ischemic brain damage in neonatal rats},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110503}
}
EUVIMED